Journal article
Cisplatin- Versus Non–Cisplatin-based First-Line Chemotherapy for Advanced Urothelial Carcinoma Previously Treated With Perioperative Cisplatin
Abstract
INTRODUCTION: The optimal choice of first-line chemotherapy for patients with relapse of urothelial carcinoma (UC) after perioperative cisplatin-based chemotherapy (PCBC) is unclear. We investigated the outcomes with cisplatin rechallenge versus a non-cisplatin regimen in patients with recurrent metastatic UC after PCBC in a multicenter retrospective study.
PATIENTS AND METHODS: Individual patient-level data were collected for patients who had …
Authors
Locke JA; Pond GR; Sonpavde G; Necchi A; Giannatempo P; Paluri RK; Niegisch G; Albers P; Buonerba C; Di Lorenzo G
Journal
Clinical Genitourinary Cancer, Vol. 14, No. 4, pp. 331–340
Publisher
Elsevier
Publication Date
August 2016
DOI
10.1016/j.clgc.2015.10.005
ISSN
1558-7673